ARTICLE | Management Tracks
Plus: Miguel Fernández Alcalde becomes president of EMD Serono, and updates from CorriXR, Acadia and HealthCare Royalty
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
December 11, 2024 12:47 AM UTC
InCarda Therapeutics Inc., which is developing therapies for cardiac arrhythmias, named Myles Greenberg president and CEO. Greenberg was president and CEO of Alucent Biomedical Inc., and is an executive char at Focused Therapeutics Inc., a company he co-founded.
Merck KGaA (Xetra:MRK) named Miguel Fernández Alcalde president of EMD Serono, the company’s U.S. and Canada business. Fernández Alcalde has been EMD’s COO for the past 18 months and joined Merck KGaA from AstraZeneca plc (LSE:AZN; NASDAQ:AZN) in 2014…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654429/myles-greenberg-named-president-ceo-of-incarda